Q4 2024 13F Holders as of 31 Dec 2024
-
Type / Class
-
Equity / Common Stock, $0.01 par value
-
Shares outstanding
-
66,587,586
-
Number of holders
-
22
-
Total 13F shares, excl. options
-
1,388,825
-
Shares change
-
+5,292
-
Total reported value, excl. options
-
$2,569,389
-
Value change
-
+$5,735
-
Number of buys
-
5
-
Number of sells
-
8
-
Price
-
$1.85
Institutional Holders of Armata Pharmaceuticals, Inc. - Common Stock, $0.01 par value (ARMP) as of Q4 2024
As of 31 Dec 2024 Armata Pharmaceuticals, Inc. - Common Stock, $0.01 par value (ARMP) had 27 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 1,388,825 shares of stock of the company.
Largest 10 holders included BANK OF AMERICA CORP /DE/, VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, EDGEWOOD MANAGEMENT LLC, BRIDGEWAY CAPITAL MANAGEMENT, LLC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, STATE STREET CORP, RENAISSANCE TECHNOLOGIES LLC, SeaCrest Wealth Management, LLC, and BlackRock, Inc..
This table shows 27 institutional shareholders of the security as of 31 Dec 2024.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.